VanEck Associates
CBST

VanEck Associates’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

VanEck Associates’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-168,606
Closed -$17M – 795
2014
Q4 		$17M Buy
168,606
+4,254
+3% +$331K 0.11% 150
2014
Q3 		$10.9M Sell
164,352
-1,950
-1% -$128K 0.06% 191
2014
Q2 		$11.6M Sell
166,302
-28,400
-15% -$1.93M 0.05% 186
2014
Q1 		$14.2M Sell
194,702
-4,439
-2% -$331K 0.07% 165
2013
Q4 		$13.7M Buy
199,141
+42,447
+27% +$2.75M 0.07% 158
2013
Q3 		$9.96M Buy
156,694
+1,638
+1% +$99K 0.05% 178
2013
Q2 		$7.49M Buy
+155,056
New +$7.62M 0.04% 182

VanEck Associates's CBST Position: Q1 2015 in Review

VanEck Associates sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2015, closing a stake of 168,606 shares — an estimated $17M sold.

VanEck Associates first reported a position in CBST in Q2 2013 and held it in 7 quarters. The position peaked at $17M in Q4 2014. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.

  • VanEck Associates reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • VanEck Associates sold 168,606 CUBIST PHARMACEUTICALS INC shares in Q1 2015, an estimated $17M.
  • VanEck Associates first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • VanEck Associates's CUBIST PHARMACEUTICALS INC position peaked at $17M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2015.

Based on VanEck Associates's 13F filing for Q1 2015, filed 14 May 2015.